Federal contract award
15B50526F00000191
EXELAN, LENALIDOMIDE 10MG CAP, JUL-SEP FY26 $351.76 X 21 $7,386.96 X 3 MONTHS $22,160.88
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Justice |
| Office | FMC CARSWELL |
| NAICS | 325412 — Pharmaceutical Preparation Manufacturing |
| PSC | Q517 — Pharmacy Services |
| Parent award / vehicle | 36F79720D0227 |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $14.8K |
| Current contract value | $14.8K |
| Potential contract value / ceiling | $14.8K |
| Start date | Jul 1, 2026 |
| Current end date | Sep 30, 2026 |
| Potential end date | Sep 30, 2026 |
| Latest award activity | Sep 4, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Sep 4, 2026 | P00001 | $-7.4K | EXELAN, LENALIDOMIDE 10MG CAP, JUL-SEP FY26 $351.76 X 21 $7,386.96 X 3 MONTHS $22,160.88 |
| Aug 3, 2026 | 0 | $22.2K | EXELAN, LENALIDOMIDE 10MG CAP, JUL-SEP FY26 $351.76 X 21 $7,386.96 X 3 MONTHS $22,160.88 |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.